Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
KRISHGEN BIOSYSTEMS Immunoassay for the estimation of Atezolizumab (TECENTRIQ) in serum and plasma. Assay Range: 20 - 640 ng/ml; Sensitivity: 80 ng/ml. Validated against ICH M10.
Supplier: KRISHGEN BIOSYSTEMS KBI1027
Pack Size: 1 x 96 wellsBackground: Atezolizumab (trade name Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). In 2015, it was in clinical trials as an immunotherapy for several types of solid tumors. It was under investigation by Genentech/Roche. In April 2016, Roche announced that atezolizumab had been granted fast track status for lung cancer by the FDA. In May 2018, Tecentriq was in combination with Avastin and standard chemotherapy for some patients with lung cancer was granted priority review. This mAb-based Atezolizumab ELISA accurately quantifies atezolizumab in human samples. If you are looking to use animal samples, please contact us. ELISA Features include a pre-coated plate with break-apart wells, standardisation and Lot to Lot Consistency with Precision CV <15%.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?